Skip to main content
Vcanbio Cell & Gene Engineering Corp., Ltd logo

Vcanbio Cell & Gene Engineering Corp., Ltd — Investor Relations & Filings

Ticker · 600645 ISIN · CNE000000545 LEI · 300300FLWFDJPQYVAZ24 Shanghai Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,580 across all filing types
Latest filing 2018-01-29 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 600645

About Vcanbio Cell & Gene Engineering Corp., Ltd

https://www.vcanbio.com/

Vcanbio Cell & Gene Engineering Corp., Ltd. specializes in the fields of cell therapy, gene technology, and precision medicine. The company operates a comprehensive business model centered on the storage of hematopoietic and mesenchymal stem cells, providing long-term bio-banking services for cord blood and other biological tissues. Its technical portfolio includes advanced genetic testing services, such as prenatal screening and oncology diagnostics, alongside the development of cell-based therapeutic products. Vcanbio maintains a network of specialized laboratories and storage facilities to support clinical research and personalized healthcare applications. The organization focuses on translating biotechnological advancements into clinical solutions, emphasizing quality control in cell processing and genomic analysis to serve the evolving needs of the regenerative medicine and diagnostic sectors.

Recent filings

Filing Released Lang Actions
第九届董事会第十一次会议决议公告
Board/Management Information Classification · 100% confidence The document is a formal announcement of resolutions passed at a board meeting of Zhongyuan Xiehe Cell Gene Engineering Co., Ltd. It details the convening of the 11th meeting of the 9th board, voting results on internal control manual revisions, and the decision to convene an extraordinary general meeting. There is no financial data, no audit or annual report content, no earnings information, and no shareholder voting results from a general meeting. The document is clearly a Board/Management Information announcement about board meeting decisions and management resolutions.
2018-01-29 Chinese
关于监事会主席辞职公告
Board/Management Information Classification · 100% confidence The document is a short announcement regarding the resignation of the chairman of the supervisory board (监事会主席辞职公告). It details the resignation, the legal implications, and the company's plan to fill the vacancy. There is no financial data, no report attached or referenced as being published, and no mention of financial results or regulatory certifications. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management.
2018-01-26 Chinese
关于控股股东部分股权质押和调整购回交易日的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement from a company regarding the pledge of shares by its controlling shareholder and adjustments to the repurchase transaction date. It details the number of shares pledged, the parties involved, and the purpose and risks of the pledge. There is no financial data, no mention of a report being attached or published, and no indication of a meeting or voting results. The content is about share pledge and financing arrangements by a major shareholder, which fits the category of Capital/Financing Update (CAP). The document length is short and it is an announcement, not a full report or certification. Therefore, the appropriate classification is CAP.
2018-01-24 Chinese
关于中源协和细胞基因工程股份有限公司股票交易异常波动问询函的回函
Regulatory Filings
2018-01-23 Chinese
股票交易异常波动公告
Regulatory Filings Classification · 95% confidence The document is a stock trading abnormal fluctuation announcement by Zhongyuan Xiehe Cell Gene Engineering Co., Ltd. It details the stock price drop over three consecutive trading days, the company's investigation into the cause, and confirms no undisclosed material information exists. It also references a major asset restructuring and related disclosures but does not contain financial statements or detailed financial data. The document is an official regulatory announcement about stock price movement and company disclosures, not a financial report or earnings release. It fits the category of Regulatory Filings (RNS) as a general regulatory announcement about stock trading abnormalities and company disclosures.
2018-01-23 Chinese
第九届董事会第十次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of a board meeting resolution regarding the appointment of a senior management officer (a new vice general manager). It includes details about the meeting, voting results, and the appointee's resume. There is no financial data, no report or presentation, and it focuses on management changes. This fits the category of Board/Management Information (MANG). The document length is short and it is not a report publication announcement or certification. Therefore, the classification is MANG with high confidence.
2018-01-22 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.